3 completed, 2 recruiting, 1 suspended. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Suspended 1 |
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Custodiol-N solution: new trials by email Literature Review of Custodiol-N solution trials Research Report on Custodiol-N solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children heart will be treated with Custodiol-N, heart will be treated with Custodiol - Congenital Heart Malformations | Phase 2 | Suspended | Dr. F. Köhler Chemie GmbH | 100 | 2024-12-05 | 2026-02-09 |
| Study of Organ Perfusion in Heart Transplantation in Children Custodiol-N, Custodiol - Heart Transplantation | Phase 2 | Recruiting | Dr. F. Köhler Chemie GmbH | 15 | 2023-08-15 | 2026-01-30 |
| Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas) Custodiol-N Solution, Custodiol HTK Solution - Kidney Failure, Liver Failure, Chronic | Phase 3 | Recruiting | Dr. F. Köhler Chemie GmbH | 362 | 2019-05-23 | 2025-09-10 |
| Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation Custodiol-N, Custodiol, organ perfusion for heart transplantation - Heart Failure | Phase 3 | Completed | Dr. F. Köhler Chemie GmbH | 105 | 2016-07-01 | 2020-01-18 |
| Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol Custodiol-N, Custodiol - Aortic Valve Disease, Coronary Artery Disease (CAD) | Phase 3 | Completed | Dr. F. Köhler Chemie GmbH | 530 | 2014-05-01 | 2020-01-18 |
| Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery Custodiol-N, Custodiol - Coronary Artery Disease (CAD) | Phase 2 | Completed | Dr. F. Köhler Chemie GmbH | 102 | 2011-03-01 | 2013-05-17 |
Coronary Artery Disease (2) · Aortic Valve Disease (1) · End Stage Liver Disease (1) · Heart Failure (1) · Renal Insufficiency (1)
Germany (5) · Austria (2)
Gabor Szabo, Prof. Dr. (2) · Christine-Elena Kamla, Dr. (1) · Christoph Knosalla, Prof. Dr. (1) · Florian Wagner, Dr. (1) · Martin Misfeld, Dr. (1) · Mohamed Salem, Dr. (1) · Nikolaus Pizanis, Dr. (1) · Philippe Grieshaber, PD Dr. (1) · Thorsten Doenst, Prof. Dr. (1)
2017 (1)